BOUL Overzicht aandelen
Boule Diagnostics AB (publ) ontwikkelt, produceert en verkoopt instrumenten en verbruiksartikelen voor bloeddiagnostiek in de Verenigde Staten, Azië, Oost-Europa, Latijns-Amerika, West-Europa, Afrika en het Midden-Oosten.
| Sneeuwvlok Score | |
|---|---|
| Waardering | 5/6 |
| Toekomstige groei | 4/6 |
| Prestaties in het verleden | 0/6 |
| Financiële gezondheid | 3/6 |
| Dividenden | 0/6 |
Boule Diagnostics AB (publ) Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | SEK 7.04 |
| 52 Week Hoogtepunt | SEK 12.62 |
| 52 Week Laag | SEK 6.70 |
| Bèta | 0.49 |
| 11 maand verandering | -17.56% |
| 3 maanden verandering | -19.45% |
| 1 Jaar Verandering | -23.73% |
| 33 jaar verandering | -86.91% |
| 5 jaar verandering | -88.55% |
| Verandering sinds IPO | -39.96% |
Recent nieuws en updates
Does Boule Diagnostics (STO:BOUL) Have A Healthy Balance Sheet?
Oct 10
Boule Diagnostics AB (publ) Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts
Jul 25Capital Allocation Trends At Boule Diagnostics (STO:BOUL) Aren't Ideal
Jul 24Recent updates
Does Boule Diagnostics (STO:BOUL) Have A Healthy Balance Sheet?
Oct 10Boule Diagnostics AB (publ) Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts
Jul 25Capital Allocation Trends At Boule Diagnostics (STO:BOUL) Aren't Ideal
Jul 24Sentiment Still Eluding Boule Diagnostics AB (publ) (STO:BOUL)
Jun 06Results: Boule Diagnostics AB (publ) Exceeded Expectations And The Consensus Has Updated Its Estimates
May 10Boule Diagnostics AB (publ) (STO:BOUL) Shares Could Be 47% Below Their Intrinsic Value Estimate
Mar 20Here's What Analysts Are Forecasting For Boule Diagnostics AB (publ) (STO:BOUL) After Its Yearly Results
Feb 09Boule Diagnostics AB (publ) (STO:BOUL) Screens Well But There Might Be A Catch
Dec 30Investors Could Be Concerned With Boule Diagnostics' (STO:BOUL) Returns On Capital
Jul 25Boule Diagnostics AB (publ) (STO:BOUL) Shares Could Be 49% Below Their Intrinsic Value Estimate
May 26Boule Diagnostics' (STO:BOUL) Solid Profits Have Weak Fundamentals
Jul 26Returns On Capital Signal Tricky Times Ahead For Boule Diagnostics (STO:BOUL)
Jul 19We Think Boule Diagnostics (STO:BOUL) Can Stay On Top Of Its Debt
Mar 06Investors Could Be Concerned With Boule Diagnostics' (STO:BOUL) Returns On Capital
Feb 03The Returns At Boule Diagnostics (STO:BOUL) Aren't Growing
Apr 29Should You Investigate Boule Diagnostics AB (publ) (STO:BOUL) At kr67.70?
Apr 09Boule Diagnostics AB (publ) (STO:BOUL) Shares Could Be 27% Below Their Intrinsic Value Estimate
Mar 25Consider This Before Buying Boule Diagnostics AB (publ) (STO:BOUL) For The 1.0% Dividend
Mar 07Is Boule Diagnostics' (STO:BOUL) 210% Share Price Increase Well Justified?
Feb 17
These 4 Measures Indicate That Boule Diagnostics (STO:BOUL) Is Using Debt Extensively
Jan 30Is Boule Diagnostics AB (publ)'s (STO:BOUL) Shareholder Ownership Skewed Towards Insiders?
Jan 14How Many Boule Diagnostics AB (publ) (STO:BOUL) Shares Did Insiders Buy, In The Last Year?
Dec 28Boule Diagnostics AB (publ) (STO:BOUL) Shares Could Be 47% Below Their Intrinsic Value Estimate
Dec 10What Do The Returns On Capital At Boule Diagnostics (STO:BOUL) Tell Us?
Nov 22Rendement voor aandeelhouders
| BOUL | SE Medical Equipment | SE Markt | |
|---|---|---|---|
| 7D | -1.7% | -4.9% | -2.3% |
| 1Y | -23.7% | 4.5% | 21.0% |
Rendement versus industrie: BOUL underperformed the Swedish Medical Equipment industry which returned 4.5% over the past year.
Rendement versus markt: BOUL underperformed the Swedish Market which returned 21% over the past year.
Prijsvolatiliteit
| BOUL volatility | |
|---|---|
| BOUL Average Weekly Movement | 7.2% |
| Medical Equipment Industry Average Movement | 7.1% |
| Market Average Movement | 5.4% |
| 10% most volatile stocks in SE Market | 10.8% |
| 10% least volatile stocks in SE Market | 3.2% |
Stabiele aandelenkoers: BOUL has not had significant price volatility in the past 3 months compared to the Swedish market.
Volatiliteit in de loop van de tijd: BOUL's weekly volatility (7%) has been stable over the past year.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 1956 | 200 | Torben Nielsen | www.boule.com |
Boule Diagnostics AB (publ) ontwikkelt, produceert en verkoopt instrumenten en verbruiksartikelen voor bloeddiagnostiek in de Verenigde Staten, Azië, Oost-Europa, Latijns-Amerika, West-Europa, Afrika en het Midden-Oosten. Het bedrijf levert hematologie-analysatoren, reagentia, controles en kalibrators onder de merknamen Swelab, Medonic en Quintus; en veterinaire hematologie- en klinisch-chemische analysesystemen, evenals reagentia en panels onder de merknaam Exigo. Het bedrijf levert aan kleine en middelgrote ziekenhuizen, klinieken, laboratoria, dierenklinieken en andere diagnostische bedrijven.
Boule Diagnostics AB (publ) Samenvatting
| BOUL fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | SEK 273.39m |
| Inkomsten(TTM) | -SEK 212.52m |
| Inkomsten(TTM) | SEK 563.33m |
0.5x
P/S-verhouding-1.3x
Koers/WinstverhoudingIs BOUL overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| BOUL resultatenrekening (TTM) | |
|---|---|
| Inkomsten | SEK 563.33m |
| Kosten van inkomsten | SEK 309.02m |
| Brutowinst | SEK 254.31m |
| Overige uitgaven | SEK 466.84m |
| Inkomsten | -SEK 212.52m |
Laatst gerapporteerde inkomsten
Sep 30, 2024
Volgende inkomensdatum
Feb 11, 2025
| Winst per aandeel (EPS) | -5.47 |
| Brutomarge | 45.14% |
| Nettowinstmarge | -37.73% |
| Schuld/Eigen Vermogen Verhouding | 64.3% |
Hoe presteerde BOUL op de lange termijn?
Bekijk historische prestaties en vergelijking